NNIDR held its National Public Lecture Tour Series in March and April 2017. The tour commenced in Sydney on 15 March 2017 during Brain Awareness Week and visited all Australian capitals. The tour was part of the Australian Government’s $200 million Boosting Dementia Research initiative.
The talks given at the Sydney event held on 15 March 2017 were recorded and can be viewed by clicking on the following links:
Free to attendees, the tour featured 2016 Ryman Prize winner, Professor Henry Brodaty AO, Co-Director of the Centre for Healthy Brain Ageing (CHeBA), UNSW Sydney. Prof Brodaty provided an insider snapshot of the current state of dementia research in Australia and internationally, and the work of the Institute.
Harry Johns, President and CEO – USA Alzheimer’s Association joined Henry during Brain Awareness Week in Sydney on 15 March and Canberra on 16 March 2017. Harry Johns is a global leader in Alzheimer's and dementia advocacy, research and support.
Access Prof Brodaty’s lecture slides.
Prof Brodaty covered:
- What is Alzheimer’s and Dementia
- Update on cause/s of AD
- Prevention of AD and dementias
- Developments in diagnosis and treatments
- Maintaining quality of life for people with dementia and their families
- Hope for the future
NHMRC National Institute for Dementia Research public lecture tour was supported by Alzheimer’s Australia, and Harry Johns’ visit to Australia was supported by the J.O. and J.R. Wicking Trust.
Scientia Professor Henry Brodaty AO
Dementia – Inspiring Hope, Retaining Realism
As well as being one of the world’s leading researchers in dementia Henry Brodaty is a clinician, a policy advisor and a strong advocate for people with dementia and their carers.
At the University of New South Wales, he is Co-Director of Centre for Healthy Brain Ageing, Scientia Professor of Ageing and Mental Health, Montefiore Chair of Healthy Brain Ageing and Director, Dementia Collaborative Research Centre. At Prince of Wales Hospital in Sydney, he is a senior psychogeriatrician and Head of the Memory Disorders Clinic.
Professor Brodaty is Immediate Past-President of the International Psychogeriatric Association and a former President of Alzheimer’s Australia NSW and Alzheimer’s Australia and Chairman of Alzheimer’s Disease International. He is a member of the Expert Advisory Panel of the NHMRC National Institute for Dementia Research, Alzheimer's Australia National Ambassador and Alzheimer's Australia Dementia Research Foundation Patron.
He has received many awards, most recently (2016), the Ryman Prize for the world’s best development, advance or achievement that enhances quality of life for older people.
Professor Brodaty has published over 500 papers, conducted many trials for treatment of Alzheimer’s disease and is currently leading the world’s largest internet based trial for the prevention of dementia.
Dementia Research - An Urgent International Priority
Harry Johns is President and CEO of the Alzheimer's Association.
The Alzheimer’s Association has driven the public discussion about Alzheimer's in America, raising it to unprecedented levels of recognition and support. The Association provides care and support in America 24 hours a day, 365 days a year, with local services across the country, a toll free Helpline, and robust information for millions each month through its website.
The Association has also achieved significant public policy advances in America, including the passage of the National Alzheimer's Project Act and the creation of the National Alzheimer's Plan, the passage of the Alzheimer’s Accountability Act and increases in federal research investments that have more than doubled the available funding, including a $350 million increase in the past year. The Association's global leadership in research includes breakthroughs that have changed the trajectory of dementia research, with over $80 million currently invested in more than 20 countries as well as annually convening the world’s largest gathering of Alzheimer's and other dementia researchers.
Harry was appointed by the US Secretary of Health and Human Services in 2011 to serve as a member of the Advisory Council on Alzheimer's Research, Care, and Services. Following the 2013 G8 Dementia Summit, he was named to the World Dementia Council. He also serves as CEO of the Alzheimer's Impact Movement and on the Executive Committee of Research in America. Prior to joining the Alzheimer's Association, he was one of the four members of the executive team of the American Cancer Society. Harry is a graduate of Eckerd College and Northwestern University's Kellogg School of Business.